Genomic Deletion of PFKFB3 Decreases In Vivo Tumorigenesis.

Imbert-Fernandez, Yoannis; Chang, Simone M; Lanceta, Lilibeth; Sanders, Nicole M; Chesney, Jason; Clem, Brian F; Telang, Sucheta

Imbert-Fernandez, Yoannis; Chang, Simone M; Lanceta, Lilibeth; Sanders, Nicole M; Chesney, Jason; Clem, Brian F; Telang, Sucheta.

Affiliation

Imbert-Fernandez Y; Department of Medicine, Division of Medical Oncology, Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.
Chang SM; Department of Pediatrics, University of Louisville, Louisville, KY 40202, USA.
Lanceta L; Department of Medicine, Division of Medical Oncology, Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.
Sanders NM; Department of Medicine, Division of Medical Oncology, Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.
Chesney J; Department of Medicine, Division of Medical Oncology, Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.
Clem BF; Department of Medicine, Division of Medical Oncology, Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA.
Telang S; Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40202, USA.

Cancers (Basel) ; 16(13)2024 Jun 26.

Article de En | MEDLINE | ID: mdl-39001392

Mots clés

Erbb2; Ras; breast cancer; glucose metabolism; glycolysis; lung cancer; metabolism; phosphofructokinase

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Cancers (Basel) Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google